Suppr超能文献

免疫性血小板减少症揭示IgG-4丰富的肾周罗萨伊-多夫曼病,利妥昔单抗成功治疗:一例报告及文献综述

Immune Thrombocytopenia Revealing Enriched IgG-4 Peri-Renal Rosai-Dorfman Disease Successfully Treated with Rituximab: A Case Report and Literature Review.

作者信息

Razanamahery Jerome, Humbert Sebastien, Emile Jean-Francois, Cohen-Aubart Fleur, Fontan Jean, Maksud Philippe, Audia Sylvain, Haroche Julien

机构信息

Internal Medicine Department and Clinical Immunology, Dijon University Hospital, Dijon, France.

Internal Medicine Department, Besancon University Hospital, Besançon, France.

出版信息

Front Med (Lausanne). 2021 Jun 16;8:678456. doi: 10.3389/fmed.2021.678456. eCollection 2021.

Abstract

Immune thrombocytopenia (ITP) is a rare autoimmune-mediated condition characterized by isolated thrombocytopenia (<100 G/L) after exclusion of other causes. Mostly primary, it is associated with hematological malignancy, autoimmune disorders, or infection in 20% of patients. It is exceptionally described in patients with histiocytosis, mostly in children (seven patients in literature). We report a case of a 69-year-old man with ITP leading to the diagnosis of histiocytosis. At ITP's diagnosis, the patient had elevated gamma-globulins leading to computed tomography showing bilateral peri-renal infiltration. The biopsy showed enriched IgG-4 peri-renal Rosai Dorfman disease with mutation, although peri-renal infiltration is highly suggestive of Erdheim-Chester disease. This overlapping association was described in men with mutation in gene. Macrophages are implicated in the pathophysiology of ITP in multiple ways, notably by the phagocytosis of opsonized platelets and their function of antigen-presenting cells able to stimulate autoreactive T cells. Histiocytic cells derivate from monocyte-macrophage lineage. Activation of macrophages in active histiocytosis is responsible for consequential platelet destruction in ITP associated histiocytosis. Finally, this case highlights a rare presentation of ITP revealing histiocytosis, both being efficiently treated with rituximab.

摘要

免疫性血小板减少症(ITP)是一种罕见的自身免疫介导性疾病,其特征为排除其他病因后出现孤立性血小板减少(<100 G/L)。多数为原发性,20%的患者与血液系统恶性肿瘤、自身免疫性疾病或感染有关。在组织细胞增多症患者中也有罕见报道,主要见于儿童(文献中有7例患者)。我们报告一例69岁男性ITP患者,最终诊断为组织细胞增多症。在诊断ITP时,患者γ球蛋白升高,计算机断层扫描显示双侧肾周浸润。活检显示富含IgG-4的肾周罗萨伊-多夫曼病伴 突变,尽管肾周浸润高度提示厄尔德海姆-切斯特病。这种重叠关联在有 基因突变的男性中已有描述。巨噬细胞以多种方式参与ITP的病理生理过程,特别是通过吞噬调理素化的血小板及其作为能够刺激自身反应性T细胞的抗原呈递细胞的功能。组织细胞来源于单核细胞-巨噬细胞谱系。活动性组织细胞增多症中巨噬细胞的激活是ITP相关组织细胞增多症中血小板破坏的原因。最后,该病例突出了ITP罕见的表现形式,揭示了组织细胞增多症,两者均可用利妥昔单抗有效治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/517b/8244783/0d85d5fa7d53/fmed-08-678456-g0001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验